Video

Impact of Long-Acting HIV Prevention Drugs

A panel of experts discuss the role of PrEP in HIV prevention with a focus on current and newly approved options.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
3 experts are featured in this series.
Related Content
3d illustration of HIV virus. Medical concept - Image credit: artegorov3@gmail | stock.adobe.com
September 4th 2025

IAS 2025: Pharmacists Steer Modern HIV Care Through Coinfection Management

Kennedy Ferruggia, Assistant Editor
Public Health Matters: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care
September 4th 2025

Public Health Matters: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care

DNA structure and HIV-infected
September 4th 2025

IAS 2025: Patients With HIV Grapple With Healthy Aging, Reducing CVD Risk

Luke Halpern, Assistant Editor
Public Health Matters: The Pharmacist's Role in the HIV Space, Removing Barriers, Racial Disparities
September 4th 2025

Public Health Matters: The Pharmacist's Role in the HIV Space, Removing Barriers, Racial Disparities

Aids HIV Virus
September 4th 2025

FDA Approves Twice-Yearly Lenacapavir for HIV Preexposure Prophylaxis

Luke Halpern, Assistant Editor
Pharmacist-Led HCV Program Uncovers Syndemic Risks, Supports Expanded Screening
September 4th 2025

Pharmacist-Led HCV Program Uncovers Syndemic Risks, Supports Expanded Screening

Aislinn Antrim, Managing Editor
© 2025 MJH Life Sciences

All rights reserved.